Precision medicine company Gemini Therapeutics attracts $42.5 mln
Cambridge, Massachusetts-based Gemini Therapeutics, a new precision medicine company , has closed $42.5 million in Series A financing. Atlas Venture, Lightstone Ventures and OrbiMed led the round.
17 October 2017•1 min read
